Select a Company
5.95 TND 0 (0%)
As of 30-Dec-2022
Adwya SA is a Tunisia-based company engaged in the provision of generic and licensed pharmaceuticals for human and veterinary use. The Company’s range of products spans several medical areas, including cardiology, dermatology, neuro-psychiatry, metabolism and nutrition, diabetes and urology, among others.
2012, 2013, 2014, 2015, 2018, 2019,
Latest Announcements
ADWYA
As of 30-Dec-2022
| SECTEUR Sante |
INDUSTRIE Pharmacie et biotechnologie |
| Symbol ADWYA |
ISIN TN0007250012 |
Adwya SA is a Tunisia-based company engaged in the provision of generic and licensed pharmaceuticals for human and veterinary use. The Company’s range of products spans several medical areas, including cardiology, dermatology, neuro-psychiatry, metabolism and nutrition, diabetes and urology, among others.
Site Web: www.adwya.com.tn
|
EXCLUSIVE OFFER
Get FULL ACCESS to AFRICAN MARKETS for 10$
Subscribe today and get full access to detailled COMPANY PROFILES, LIBRARY and MARKET DATA:
1500+ listed companies (overview, interactive chart, market activity, shareholding, dividends, ...) 11000+ annual reports & financial statements (Unlimited PDF downloads) 17 Market indices Historical market data (Unlimited Excel Download)
You will enjoy all the exclusive features of African-markets.com including our Premium stories and research papers. Click here for a sample company profile.
|
Rapports Annuels disponibles
2012, 2013, 2014, 2015, 2018, 2019,
Latest Announcements
| ADWYA | Offre publique de retrait | 04-01-2023 |
| ADWYA | Suspension de la cotation | 28-11-2022 |
| ADWYA | Offre publique de retrait | 28-11-2022 |
| ADWYA | Communiqué du CMF | 25-11-2022 |
| ADWYA | Indicateurs d'activité | 20-10-2022 |
| ADWYA | Mise à jour du flottant | 22-09-2022 |
| ADWYA | Resultat de l'offre publique d’achat | 20-09-2022 |
| ADWYA | Offre publique d’achat | 16-08-2022 |
| ADWYA | Suspension de la cotation | 16-08-2022 |
| ADWYA | Communiqué du CMF | 16-08-2022 |